Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,324
Sort by:
Latin America Clinical Chemistry Analyzers and Reagents Market, 2019-2023: A 7-Country Analysis-Emerging Opportunities, Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review
US$ 8,750.00
... , cancer, immunoprotein and abused drug assays. Individual Tests Analyzed in the Report Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST ...
May 2019
620 pages
Middle East Clinical Chemistry Analyzers and Reagents Market, 2019-2023: An 11-Country Analysis-Emerging Opportunities, Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review
US$ 11,500.00
... , cancer, immunoprotein and abused drug assays. Individual Tests Analyzed in the Report Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST ...
May 2019
700 pages
New Zealand Clinical Chemistry Reagents and Analyzers Market Analysis, 2019-2023: Supplier Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 3,750.00
... The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and ... new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators. Tests Analyzed in the Report: Routine Clinical Chemistry ...
May 2019
517 pages
North America Clinical Chemistry Analyzers and Reagents Market, 2019-2023: USA, Canada, Mexico-Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 13,500.00
... , cancer, immunoprotein and abused drug assays. Individual Tests Analyzed in the Report Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST ...
May 2019
635 pages
